HomeProduct Newsletter Vitamins China E-News

Vitamins China E-News

Publication: Monthly on the
Published by CCM

Vitamins China E-News provides you with real-time intelligence on China's vitamins market.
 
China is the world's largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.
 
Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
      
  • Breaking news from China and abroad
    •   
  • The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
    •   
  • In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
    •   
  • Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
Vitamins China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.

www.cnchemicals.com www.cnchemicals.com

  • Future-issues subscription

Starting from the issue of
202404
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,950.00
  • Corporate license:
    USD 7,375.00

All the prices on this website exclude VAT.
<<
  • 202404
  • 202403
  • 202402
  • 202401
  • 202312
  • 202311
  • 202310
  • 202309
  • 202308
  • 202307
  • 202306
  • 202305
  • 202304
  • 202303
  • 202302
  • 202301
  • 202212
  • 202211
  • 202210
  • 202209
  • 202208
  • 202207
  • 202206
  • 202205
  • 202204
  • 202203
  • 202202
  • 202201
  • 202112
  • 202111
  • 202110
  • 202109
  • 202108
  • 202107
  • 202106
  • 202105
  • 202104
  • 202103
  • 202102
  • 202101
  • 202012
  • 202011
  • 202010
  • 202009
  • 202008
  • 202007
  • 202006
  • 202005
  • 202004
  • 202003
  • 202002
  • 202001
  • 201912
  • 201911
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201706
  • 201705
  • 201704
  • 201703
  • 201702
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
  • 201505
  • 201504
  • 201503
  • 201502
  • 201501
  • 201412
  • 201411
  • 201410
>>

Main Content of Vitamins China E-News 201703

Price of this issue :
USD 98

Published on 30th March, 2017

Affected by continual environmental pressure in 2017, leading VC producers CSPC Pharmaceutical and North China Pharmaceutical planned to cut production, further tightening the market supply. Meanwhile, demand for VC is expected to be boosted by seasonal sales peak in the livestock market. For these reasons, VC price may keep high in H1, but is likely to fluctuate in H2 as Northeast Pharmaceutical puts its new production project into operation.

Published on 30th March, 2017

On 20 March, 2017, CSPC Pharmaceutical issued its 2016 financial report, indicating a YoY growth of 26.20% in net profit due to the increased finished drug sales and financial turnaround in VC business.

Published on 30th March, 2017

In early 2017, many Chinese producers of vitamin functional beverages launched their new products to capture larger market shares, intensifying the market competition.

Published on 30th March, 2017

Exports of VB1 from China are estimated to increase just slightly in 2017, given the stable domestic production and overseas demand. As the environmental policies become more stringent, domestic producers are confronted with increased production costs, and show weak inclination to expand production.

Published on 30th March, 2017

Published on 29th March, 2017

Published on 29th March, 2017

Published on 29th March, 2017

Published on 29th March, 2017

Published on 29th March, 2017

Published on 29th March, 2017

Published on 29th March, 2017

Published on 24th March, 2017

Published on 24th March, 2017

Published on 24th March, 2017

Published on 24th March, 2017

Brother Enterprises recorded significant financial growth in 2016, mainly thanks to the increased sales prices of VB1 and VB3.

Published on 24th March, 2017

In recent two years, the price of VD3 has been down (Feb. 2017 saw price down of 22.62% year on year). Under the stricter environmental regulations, downward price will inevitably intensify concentration ratio, so for the sake of balance between cost and profit, the price of VD is expected to go up.

Published on 24th March, 2017

In March, 2017, Nenter completed trial production of its 20,000 t/a VE project and has already had products available to the market. As more new projects are put into production and supply increases, the domestic VE market kept fluctuating in early 2017. Yet, Nenter is still expected to profit from its VE business given its competitive production costs.

Published on 24th March, 2017

VB prices are expected to keep high in the Chinese market in H1 2017, mainly due to increasing raw material prices, strengthened environmental regulations, and raised quotations from leading producers. Yet, VB3 and VB5 prices may fall slightly in H2, as new production projects are put into production.

Published on 22nd March, 2017

Published on 17th March, 2017

On 4 March, 2017, the 9th National Pharmaceuticals Industry Symposium was held in Beijing. At the conference, deputies suggested relaxing production license regulation or introducing DMF system in order to depress the price hikes in APIs like vitamins. If implemented, the monopolised vitamin API manufacturing industry may be impacted to some extent.

Published on 17th March, 2017

On 28 Feb., 2017, Guangji Pharmaceutical announced significant rises in 2016 financial performance, mainly thanks to the increased sales of its VB2 and VB6. As national environmental regulations become more stringent and production further concentrated, the company is likely to continue making great achievements in VB2 and VB6 businesses in 2017.

CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement